We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sabra Healthcare Reit - 7.125% Preferred Series A (delisted) | NASDAQ:SBRAP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.40 | 23.32 | 27.39 | 0 | 01:00:00 |
From May 2019 to May 2024
A conference call with a simultaneous webcast to discuss the 2018 fourth quarter results will be held on Monday, February 25 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 2758908.
The webcast URL is https://edge.media-server.com/m6/p/gfy3ywbv. A digital replay of the call will be available on our website at www.sabrahealth.com.
Also, on February 5, 2019, Sabra's board of directors declared a quarterly cash dividend of $0.45 per share of common stock. The dividend will be paid on February 28, 2019 to common stockholders of record as of the close of business on February 15, 2019.
Lastly, on February 1, 2019, S&P Global Ratings issued a report re-affirming Sabra’s issuer rating, senior unsecured notes rating and stable outlook.
The S&P Global Ratings report can be found on its website at www.standardandpoors.com/ratings.
About Sabra
Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
CONTACT:
Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com
1 Year Sabra Healthcare Reit - 7.125% Preferred Series A (delisted) Chart |
1 Month Sabra Healthcare Reit - 7.125% Preferred Series A (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions